Charles River Laboratories International, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $1.09B | $1.05B | $163.8M |
| FY2018 | $1.63B | $1.32B | $195.4M |
| FY2019 | $1.85B | $1.63B | $238.0M |
| FY2020 | $1.93B | $2.11B | $228.4M |
| FY2021 | $2.66B | $2.53B | $241.2M |